{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:38:14Z","timestamp":1792712294204,"version":"4.5.0"},"reference-count":73,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","award":["DE-AC02-76SF00515"],"award-info":[{"award-number":["DE-AC02-76SF00515"]}],"id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["ACB-12002"],"award-info":[{"award-number":["ACB-12002"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006132","name":"Office of Science","doi-asserted-by":"publisher","award":["DE-SC0012704"],"award-info":[{"award-number":["DE-SC0012704"]}],"id":[{"id":"10.13039\/100006132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006132","name":"Office of Science","doi-asserted-by":"publisher","award":["DE-AC02-06CH11357"],"award-info":[{"award-number":["DE-AC02-06CH11357"]}],"id":[{"id":"10.13039\/100006132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI168251"],"award-info":[{"award-number":["AI168251"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI086230"],"award-info":[{"award-number":["AI086230"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI168917"],"award-info":[{"award-number":["AI168917"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI168048"],"award-info":[{"award-number":["AI168048"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["AI158193"],"award-info":[{"award-number":["AI158193"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006206","name":"Biological and Environmental Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006206","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P30GM133894"],"award-info":[{"award-number":["P30GM133894"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["AGM-12006"],"award-info":[{"award-number":["AGM-12006"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P30GM138396"],"award-info":[{"award-number":["P30GM138396"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.celrep.2026.117760","type":"journal-article","created":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:24:51Z","timestamp":1785875091000},"page":"117760","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The conserved bridging domain on HCV E1E2 glycoprotein complex is targeted by neutralizing antibodies from diverse lineages"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3481-3363","authenticated-orcid":false,"given":"Fang","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen Thi","family":"Kim Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Zong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erick","family":"Giang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sing Chau","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiye","family":"Koide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shr-Hau","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn A.","family":"Ueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linling","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Toth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Fuerst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9792-4271","authenticated-orcid":false,"given":"Georg M.","family":"Lauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn L.","family":"Stanfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian A.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8934-9756","authenticated-orcid":false,"given":"Mansun","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2026.117760_bib1","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1053\/j.gastro.2019.11.282","article-title":"Antibody responses to immunization with HCV envelope glycoproteins as a baseline for B-cell-based vaccine development","volume":"158","author":"Chen","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.celrep.2026.117760_bib2","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.immuni.2021.02.013","article-title":"Functional convergence of a germline-encoded neutralizing antibody response in rhesus macaques immunized with HCV envelope glycoproteins","volume":"54","author":"Chen","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2026.117760_bib3","doi-asserted-by":"crossref","first-page":"10149","DOI":"10.1073\/pnas.0403519101","article-title":"Neutralizing antibody response during acute and chronic hepatitis C virus infection","volume":"101","author":"Logvinoff","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117760_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165047","article-title":"Hepatitis C virus broadly neutralizing monoclonal antibodies isolated 25 years after spontaneous clearance","volume":"11","author":"Merat","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2026.117760_bib5","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92872","article-title":"Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearance","volume":"2","author":"Bailey","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.celrep.2026.117760_bib6","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1016\/j.vaccine.2010.06.084","article-title":"Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults","volume":"28","author":"Frey","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.celrep.2026.117760_bib7","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1002\/hep.26744","article-title":"Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource","volume":"59","author":"Smith","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.celrep.2026.117760_bib8","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3389\/fimmu.2018.00910","article-title":"Glycan shielding and modulation of hepatitis C virus neutralizing antibodies","volume":"9","author":"Lavie","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2026.117760_bib9","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12929-020-00669-4","article-title":"Hepatitis C virus vaccine design: focus on the humoral immune response","volume":"27","author":"Sepulveda-Crespo","year":"2020","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.celrep.2026.117760_bib10","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.abn9884","article-title":"Structure of the hepatitis C virus E1E2 glycoprotein complex","volume":"378","author":"Torrents de la Pe\u00f1a","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.celrep.2026.117760_bib11","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/s41586-024-07783-5","article-title":"The hepatitis C virus envelope protein complex is a dimer of heterodimers","volume":"633","author":"Augestad","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117760_bib12","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/nrmicro3098","article-title":"The ins and outs of hepatitis C virus entry and assembly","volume":"11","author":"Lindenbach","year":"2013","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.celrep.2026.117760_bib13","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.3389\/fimmu.2018.01411","article-title":"Role of hepatitis C virus envelope glycoprotein E1 in virus entry and assembly","volume":"9","author":"Tong","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2026.117760_bib14","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.3389\/fimmu.2018.01315","article-title":"The neutralizing face of hepatitis C virus E2 envelope glycoprotein","volume":"9","author":"Tzarum","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2026.117760_bib15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nm1698","article-title":"Broadly neutralizing antibodies protect against hepatitis c virus quasispecies challenge","volume":"14","author":"Law","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2026.117760_bib16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.immuni.2021.12.003","article-title":"Analysis of antibodies from HCV elite neutralizers identifies genetic determinants of broad neutralization","volume":"55","author":"Weber","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2026.117760_bib17","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.coviro.2019.02.004","article-title":"VH1-69 antiviral broadly neutralizing antibodies: Genetics, structures, and relevance to rational vaccine design","volume":"34","author":"Chen","year":"2019","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.celrep.2026.117760_bib18","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1038\/s41467-023-39659-z","article-title":"Structure of engineered hepatitis C virus E1E2 ectodomain in complex with neutralizing antibodies","volume":"14","author":"Metcalf","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.117760_bib19","doi-asserted-by":"crossref","first-page":"6205","DOI":"10.1073\/pnas.1114927109","article-title":"Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus","volume":"109","author":"Giang","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117760_bib20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jhep.2019.02.013","article-title":"Cross-genotype AR3-specific neutralizing antibodies confer long-term protection in injecting drug users after HCV clearance","volume":"71","author":"Merat","year":"2019","journal-title":"J. Hepatol."},{"key":"10.1016\/j.celrep.2026.117760_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02070-18","article-title":"Broadly neutralizing antibodies targeting new sites of vulnerability in hepatitis C virus E1E2","volume":"93","author":"Colbert","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2026.117760_bib22","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2015149118","article-title":"Design of a native-like secreted form of the hepatitis C virus E1E2 heterodimer","volume":"118","author":"Guest","year":"2021","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117760_bib23","article-title":"B cell transcriptomics reveals lasting dysregulation and rapid decline of protective immune memory after chronic hepatitis C cure","volume":"2025","author":"Chen","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.celrep.2026.117760_bib24","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.53169","article-title":"An ultralong CDRH2 in HCV neutralizing antibody demonstrates structural plasticity of antibodies against E2 glycoprotein","volume":"9","author":"Flyak","year":"2020","journal-title":"eLife"},{"key":"10.1016\/j.celrep.2026.117760_bib25","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.immuni.2024.03.001","article-title":"Convergent evolution and targeting of diverse E2 epitopes by human broadly neutralizing antibodies are associated with HCV clearance","volume":"57","author":"Ogega","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.celrep.2026.117760_bib26","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1038\/s41467-026-69418-9","article-title":"Native-like soluble E1E2 glycoprotein heterodimers on self-assembling protein nanoparticles for hepatitis C virus vaccine design","volume":"17","author":"He","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.117760_bib27","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb5642","article-title":"An alternate conformation of HCV E2 neutralizing face as an additional vaccine target","volume":"6","author":"Tzarum","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.celrep.2026.117760_bib28","doi-asserted-by":"crossref","first-page":"6147","DOI":"10.1128\/jvi.68.10.6147-6160.1994","article-title":"Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses","volume":"68","author":"Dubuisson","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2026.117760_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006735","article-title":"Probing the antigenicity of hepatitis C virus envelope glycoprotein complex by high-throughput mutagenesis","volume":"13","author":"Gopal","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.celrep.2026.117760_bib30","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1126\/science.1243876","article-title":"Hepatitis C virus E2 envelope glycoprotein core structure","volume":"342","author":"Kong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.celrep.2026.117760_bib31","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav1882","article-title":"Genetic and structural insights into broad neutralization of hepatitis C virus by human VH1-69 antibodies","volume":"5","author":"Tzarum","year":"2019","journal-title":"Sci. Adv."},{"key":"10.1016\/j.celrep.2026.117760_bib32","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2026.117760_bib33","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz6225","article-title":"Proof of concept for rational design of Hepatitis C virus E2 core nanoparticle vaccines","volume":"6","author":"He","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.celrep.2026.117760_bib34","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41467-023-36183-y","article-title":"Regions of hepatitis C virus E2 required for membrane association","volume":"14","author":"Kumar","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.117760_bib35","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/s42003-025-08239-w","article-title":"Cryo-EM structures of HCV E2 glycoprotein bound to neutralizing and non-neutralizing antibodies determined using bivalent Fabs as fiducial markers","volume":"8","author":"Shahid","year":"2025","journal-title":"Commun. Biol."},{"key":"10.1016\/j.celrep.2026.117760_bib36","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1053\/j.gastro.2021.10.005","article-title":"An antigenically diverse, representative panel of envelope glycoproteins for hepatitis C virus vaccine development","volume":"162","author":"Salas","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.celrep.2026.117760_bib37","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/j.1744-7348.1939.tb06990.x","article-title":"The toxicity of poisons applied jointly","volume":"26","author":"Bliss","year":"1939","journal-title":"Ann. Appl. Biol."},{"key":"10.1016\/j.celrep.2026.117760_bib38","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/s41577-023-00858-w","article-title":"Antiviral neutralizing antibodies: from in vitro to in vivo activity","volume":"23","author":"Burton","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.celrep.2026.117760_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.689006","article-title":"Identification and characteristics of fusion peptides derived from enveloped viruses","volume":"9","author":"Lozada","year":"2021","journal-title":"Front. Chem."},{"key":"10.1016\/j.celrep.2026.117760_bib40","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.cell.2013.03.018","article-title":"Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization","volume":"153","author":"Klein","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.celrep.2026.117760_bib41","doi-asserted-by":"crossref","first-page":"9499","DOI":"10.1073\/pnas.1202924109","article-title":"Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1","volume":"109","author":"Kong","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117760_bib42","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.chom.2018.10.009","article-title":"HCV broadly neutralizing antibodies use a CDRH3 disulfide motif to recognize an E2 glycoprotein site that can be targeted for vaccine design","volume":"24","author":"Flyak","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2026.117760_bib43","doi-asserted-by":"crossref","first-page":"E82","DOI":"10.1073\/pnas.1718441115","article-title":"Synergistic anti-HCV broadly neutralizing human monoclonal antibodies with independent mechanisms","volume":"115","author":"Mankowski","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117760_bib44","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2420402122","article-title":"Bispecific antibodies against the hepatitis C virus E1E2 envelope glycoprotein","volume":"122","author":"Radi\u0107","year":"2025","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117760_bib69","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1128\/JVI.01872-07","article-title":"Isolation and characterization of broadly neutralizing human monoclonal antibodies to the E1 glycoprotein of hepatitis C virus","volume":"82","author":"Meunier","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2026.117760_bib70","doi-asserted-by":"crossref","first-page":"12473","DOI":"10.1128\/JVI.01138-09","article-title":"Identification and characterization of broadly neutralizing human monoclonal antibodies directed against the E2 envelope glycoprotein of hepatitis C virus","volume":"83","author":"Broering","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2026.117760_bib71","doi-asserted-by":"crossref","first-page":"12768","DOI":"10.1073\/pnas.1609780113","article-title":"Structural flexibility at a major conserved antibody target on hepatitis C virus E2 antigen","volume":"113","author":"Kong","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117760_bib72","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.282.5390.938","article-title":"Binding of hepatitis C virus to CD81","volume":"282","author":"Pileri","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.celrep.2026.117760_bib45","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jim.2016.09.001","article-title":"Refined protocol for generating monoclonal antibodies from single human and murine B cells","volume":"438","author":"Ho","year":"2016","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.celrep.2026.117760_bib73","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jim.2007.09.017","article-title":"Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning","volume":"329","author":"Tiller","year":"2008","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.celrep.2026.117760_bib46","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/s41590-021-00982-6","article-title":"Differentiation of exhausted CD8+ T cells after termination of chronic antigen stimulation stops short of achieving functional T cell memory","volume":"22","author":"Tonnerre","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.celrep.2026.117760_bib47","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/jvh.13041","article-title":"Dynamic changes in innate immune responses during direct-acting antiviral therapy for HCV infection","volume":"26","author":"Holmes","year":"2019","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.celrep.2026.117760_bib48","article-title":"Induction of broadly neutralizing antibodies using a secreted form of the hepatitis C virus E1E2 heterodimer as a vaccine candidate","volume":"119","author":"Wang","year":"2022","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117760_bib49","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nprot.2016.009","article-title":"In vitro reconstitution of B cell receptor-antigen interactions to evaluate potential vaccine candidates","volume":"11","author":"Weaver","year":"2016","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.celrep.2026.117760_bib50","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.20021756","article-title":"Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes","volume":"197","author":"Bartosch","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.celrep.2026.117760_bib51","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/hep.20542","article-title":"Characterization of host-range and cell entry properties of the major genotypes and subtypes of hepatitis C virus","volume":"41","author":"Lavillette","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.celrep.2026.117760_bib52","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1128\/JVI.02877-14","article-title":"Efficient infectious cell culture systems of the hepatitis C virus (HCV) prototype strains HCV-1 and H77","volume":"89","author":"Li","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.celrep.2026.117760_bib53","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1073\/pnas.0501275102","article-title":"Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1","volume":"102","author":"Meunier","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117760_bib54","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/978-1-4939-8976-8_30","article-title":"Standardized method for the study of antibody neutralization of HCV pseudoparticles (HCVpp)","volume":"1911","author":"Bailey","year":"2019","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.celrep.2026.117760_bib55","doi-asserted-by":"crossref","first-page":"W488","DOI":"10.1093\/nar\/gkaa216","article-title":"SynergyFinder 2.0: visual analytics of multi-drug combination synergies","volume":"48","author":"Ianevski","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2026.117760_bib56","doi-asserted-by":"crossref","first-page":"W739","DOI":"10.1093\/nar\/gkac382","article-title":"SynergyFinder 3.0: an interactive analysis and consensus interpretation of multi-drug synergies across multiple samples","volume":"50","author":"Ianevski","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.celrep.2026.117760_bib57","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jsb.2006.05.009","article-title":"EMAN2: an extensible image processing suite for electron microscopy","volume":"157","author":"Tang","year":"2007","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.celrep.2026.117760_bib58","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nmeth.4169","article-title":"cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination","volume":"14","author":"Punjani","year":"2017","journal-title":"Nat. Methods"},{"key":"10.1016\/j.celrep.2026.117760_bib59","doi-asserted-by":"crossref","DOI":"10.1002\/pro.4792","article-title":"UCSF ChimeraX: Tools for structure building and analysis","volume":"32","author":"Meng","year":"2023","journal-title":"Protein Sci."},{"key":"10.1016\/j.celrep.2026.117760_bib60","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of X-ray diffraction data collected in oscillation mode","volume":"276","author":"Otwinowski","year":"1997","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.celrep.2026.117760_bib61","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1107\/S0907444909047337","article-title":"XDS","volume":"66","author":"Kabsch","year":"2010","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.celrep.2026.117760_bib62","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1107\/S0907444902016657","article-title":"PHENIX: Building new software for automated crystallographic structure determination","volume":"58","author":"Adams","year":"2002","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.celrep.2026.117760_bib63","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1039\/C9ME00020H","article-title":"Repertoire builder: High-throughput structural modeling of B and T cell receptors","volume":"4","author":"Schritt","year":"2019","journal-title":"Mol. Syst. Des. Eng."},{"key":"10.1016\/j.celrep.2026.117760_bib64","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.chom.2018.10.009","article-title":"HCV broadly neutralizing antibodies use a CDRH3 disulfide motif to recognize an E2 glycoprotein site that can be targeted for vaccine design","volume":"24","author":"Flyak","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.celrep.2026.117760_bib65","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: Model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.celrep.2026.117760_bib66","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/pro.3330","article-title":"MolProbity: More and better reference data for improved all-atom structure validation","volume":"27","author":"Williams","year":"2018","journal-title":"Protein Sci."},{"key":"10.1016\/j.celrep.2026.117760_bib67","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","article-title":"Inference of macromolecular assemblies from crystalline state","volume":"372","author":"Krissinel","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.celrep.2026.117760_bib68","doi-asserted-by":"crossref","first-page":"3832","DOI":"10.1016\/j.molimm.2008.05.022","article-title":"Analysis and improvements to Kabat and structurally correct numbering of antibody variable domains","volume":"45","author":"Abhinandan","year":"2008","journal-title":"Mol. Immunol."}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726008387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726008387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:47:35Z","timestamp":1792709255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124726008387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":73,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2211124726008387"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117760","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The conserved bridging domain on HCV E1E2 glycoprotein complex is targeted by neutralizing antibodies from diverse lineages","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117760","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117760"}}